Insulet Stock Hits 52-Week Low - Here's Why - Insulet (NASDAQ:PODD)
Insulet recalled about 1.5% of Omnipod 5 pods after detecting tubing tears that may cause insulin leakage and serious health risks, including diabetic ketoacidosis.
7 Articles
7 Articles
Insulet Stock Hits 52-Week Low - Here's Why - Insulet (NASDAQ:PODD)
Insulet Corp. (NASDAQ:PODD) shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods. Manufacturing Defect Insulet identified a manufacturing issue affecting specific lots of Omnipod 5 Pods, which may have a small tear in the internal tubing that delivers insulin. This could lead to under-delivery of insulin, potentially resulting in high bl…
Insulin Pod Manufacturer Recalls US Products Over Leakage Risk
Insulet Corporation, a company that makes the most prescribed wearable insulin pump in the United States, has voluntarily recalled some of its pod devices March 12 after finding the items may leak, sending some users to the hospital. The recall includes some batches of Omnipod 5 Pods distributed in the United States, according to the company. “Insulet has received 18 reports of serious adverse events associated with high blood glucose levels, in…
Insulet issues warning on certain Omnipod 5 pumps
The Omnipod 5 hybrid closed-loop insulin delivery system worn on the back of an arm. [Image courtesy of Insulet]Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods. Omnipod 5 — the world’s first available tubeless, wearable, automated insulin delivery system — is a patch-based pump system designed to proactively correct for glucose highs every five minutes and protect again…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium



